Additionally, AMPs from other sources have proven effective in managing pediatric infections, and clinical trials have highlighted cationic antimicrobial peptides as promising alternatives for treating infections in neonates and children, especially in cases involving antibiotic-resistant pathogens [158]. Here, ADSL is linked to infection.